Investor Relations


Management Team

Fady Boctor - President, Chief Commercial Officer
Fady Boctor

Mr. Boctor has over 20 years of experience in the pharmaceutical industry, across a wide array of functions including brand and portfolio marketing, sales channel optimization, product portfolio strategy development and new product launches. Mr. Boctor has driven significant revenue growth for specialty biologics, mainstream Men’s Health product lines, rare/orphan disease therapeutics, and substance abuse rescue modalities. Mr. Boctor has worked for companies such as Novartis, Forest Pharmaceuticals, Auxilium Pharmaceuticals, Endo Pharmaceuticals and Adapt Pharmaceuticals (Emergent Biosolutions). Mr. Boctor has his BA in International Relations from Hamline University, Masters in Diplomacy from Norwich University and his MBA from the University of Manchester Business School.

Mitch Arnold - VP of Finance, Chief Accounting Officer

Coming Soon

Robert Weinstein - Interim Chief Financial Officer
Robert Weinstein

Coming Soon

Andy Gesek - President of Timm Medical Technologies (subsidiary of Petros Pharmaceuticals)
Andy Gesek

Mr. Gesek brings over 20 years of diverse commercial and financial experience in the pharmaceutical industry. After starting his career in finance at Janssen Pharmaceutical, Mr. Gesek transitioned to pharmaceutical sales and has worked in areas that include: finance, sales, sales operations, forecasting, valuation commercial analytics, business development and corporate strategy in companies including Janssen, Novartis, Pharmacia & Upjohn, Wyeth, Pfizer, Endo, and BTG. Prior to taking on his role at timm medical, Mr. Gesek served as Vice President, Commercial Operations and Business Strategy & General Manager, Established Brands Portfolio for Endo Pharmaceuticals. Here he worked closely with the President of the Branded Pharmaceuticals business to set, measure and refine the strategy for the business unit leading a team of 20 who provided operational support to the business. Mr. Gesek is a graduate of Drexel and the Wharton School of Business.